secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001628280-25-044357
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem updates TTM revenue to ~$140M, adj EBITDA ~$30M; net leverage 0.86x
------------------------------------------------------------------------------

- TTM 6/30/25 net revenue ~$140M, up from $134.9M in FY2024; adjusted EBITDA ~$30M vs. $25.3M.
- Net leverage 0.86x, debt/equity 0.85x, total available liquidity $49.1M.
- Share repurchase: $7.6M bought under $20M program through June 30, 2025.
- Patient Services gross margin 64.5% TTM; Device Solutions gross margin 39.6% TTM.
- Management estimates FY2025 revenue growth 6-8% and adjusted EBITDA margin >20%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025044357/0001628280-25-044357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025044357/infu-20251006.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-044357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer